Andrew D. Nash

5.9k total citations
76 papers, 3.7k citations indexed

About

Andrew D. Nash is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Andrew D. Nash has authored 76 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 24 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Andrew D. Nash's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Immune Response and Inflammation (11 papers) and Angiogenesis and VEGF in Cancer (10 papers). Andrew D. Nash is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Immune Response and Inflammation (11 papers) and Angiogenesis and VEGF in Cancer (10 papers). Andrew D. Nash collaborates with scholars based in Australia, United Kingdom and United States. Andrew D. Nash's co-authors include Arna E. Andrews, Louis Fabri, Douglas J. Hilton, Pierre Scotney, Garry Barcham, Nicos A. Nicola, Manuel Baca, Els Meeusen, Tracy A. Willson and Donald Metcalf and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Andrew D. Nash

74 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew D. Nash Australia 30 1.4k 1.3k 931 422 282 76 3.7k
Yasushi Hanakawa Japan 37 1.6k 1.2× 1.2k 0.9× 951 1.0× 259 0.6× 455 1.6× 76 4.4k
Rami Hershkoviz Israel 35 1.2k 0.8× 1.4k 1.1× 548 0.6× 280 0.7× 154 0.5× 98 3.9k
Gerald Grütz Germany 25 966 0.7× 1.1k 0.9× 501 0.5× 354 0.8× 231 0.8× 39 2.8k
Dagmar Scheel‐Toellner United Kingdom 35 1.9k 1.4× 2.5k 1.9× 1.0k 1.1× 462 1.1× 141 0.5× 63 5.4k
Javier Mestas United States 16 1.3k 1.0× 2.1k 1.7× 1.1k 1.2× 593 1.4× 139 0.5× 23 4.7k
Takao Hirano Japan 27 1.2k 0.8× 1.4k 1.1× 1.1k 1.2× 360 0.9× 97 0.3× 89 4.1k
Giorgio Senaldi United States 37 1.8k 1.3× 2.2k 1.8× 858 0.9× 633 1.5× 203 0.7× 106 5.1k
Brent Johnston Canada 37 705 0.5× 2.6k 2.1× 1.2k 1.3× 401 1.0× 193 0.7× 72 4.3k
Marko Pesu Finland 26 822 0.6× 1.3k 1.0× 1.0k 1.1× 272 0.6× 315 1.1× 62 3.1k
Yasuhiko Masuho Japan 34 1.8k 1.3× 1.5k 1.2× 465 0.5× 626 1.5× 133 0.5× 115 4.2k

Countries citing papers authored by Andrew D. Nash

Since Specialization
Citations

This map shows the geographic impact of Andrew D. Nash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Nash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Nash more than expected).

Fields of papers citing papers by Andrew D. Nash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Nash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Nash. The network helps show where Andrew D. Nash may publish in the future.

Co-authorship network of co-authors of Andrew D. Nash

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Nash. A scholar is included among the top collaborators of Andrew D. Nash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Nash. Andrew D. Nash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oon, Shereen, Huy Huynh, Tsin Yee Tai, et al.. (2016). A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 1(6). e86131–e86131. 26 indexed citations
2.
Busfield, Samantha J., Mark Biondo, Hayley S. Ramshaw, et al.. (2014). Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC. Leukemia. 28(11). 2213–2221. 106 indexed citations
3.
Hagberg, Carolina E., Annika Mehlem, Annelie Falkevall, et al.. (2012). Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes. Nature. 490(7420). 426–430. 223 indexed citations
4.
Adams, Timothy E., John D. Bentley, Louis Lu, et al.. (2009). A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activity in vivo. Growth Factors. 27(3). 141–154. 17 indexed citations
5.
Leonard, Philip M., Pierre Scotney, T. Jabeen, et al.. (2008). Crystal Structure of Vascular Endothelial Growth Factor-B in Complex with a Neutralising Antibody Fab Fragment. Journal of Molecular Biology. 384(5). 1203–1217. 13 indexed citations
6.
Iyer, Shalini, Pierre Scotney, Andrew D. Nash, & K. Ravi Acharya. (2006). Crystal Structure of Human Vascular Endothelial Growth Factor-B: Identification of Amino Acids Important for Receptor Binding. Journal of Molecular Biology. 359(1). 76–85. 34 indexed citations
7.
Nash, Andrew D., Manuel Baca, Christine E. Wright, & Pierre Scotney. (2005). The biology of vascular endothelial growth factor-B (VEGF-B). Pulmonary Pharmacology & Therapeutics. 19(1). 61–69. 73 indexed citations
8.
Dunphy, Jillian L., Garry Barcham, Robert J. Bischof, et al.. (2002). Isolation and Characterization of a Novel Eosinophil-specific Galectin Released into the Lungs in Response to Allergen Challenge. Journal of Biological Chemistry. 277(17). 14916–14924. 84 indexed citations
9.
Scrofani, Sergio D. B. & Andrew D. Nash. (2001). Towards a structure-function relationship for vascular endothelial growth factor-B (VEGF-B). Journal of Microbiology and Biotechnology. 11(4). 543–551. 2 indexed citations
10.
Alexander, Warren S., Steven Rakar, Lorraine Robb, et al.. (1999). Suckling defect in mice lacking the soluble haemopoietin receptor NR6. Current Biology. 9(11). 605–S1. 67 indexed citations
11.
Egan, Paul J., Wayne G. Kimpton, Heng Fong Seow, et al.. (1996). Inflammation‐induced changes in the phenotype and cytokine profile of cells migrating through skin and afferent lymph. Immunology. 89(4). 539–546. 36 indexed citations
12.
Bowles, Vernon M, Els Meeusen, Anna R. Young, et al.. (1996). Vaccination of sheep against larvae of the sheep blowfly (Lucilia cuprina). Vaccine. 14(14). 1347–1352. 28 indexed citations
13.
Lofthouse, Shari A., Arna E. Andrews, Martin J. Elhay, et al.. (1996). Cytokines as adjuvants for ruminant vaccines. International Journal for Parasitology. 26(8-9). 835–842. 29 indexed citations
14.
Egan, Paul J. & Andrew D. Nash. (1996). Differential synthesis, cellular localisation and secretion of interleukin-1α and interleukin-1β from ovine macrophages. Veterinary Immunology and Immunopathology. 55(1-3). 163–174. 2 indexed citations
15.
Lofthouse, Shari A., Arna E. Andrews, Garry Barcham, & Andrew D. Nash. (1995). Parameters related to the application of recombinant ovine interleukin-1β as an adjuvant. Vaccine. 13(14). 1277–1287. 20 indexed citations
16.
Barcham, Garry, Arna E. Andrews, & Andrew D. Nash. (1995). Cloning and expression of a cDNA encoding ovine interleukin 7. Gene. 154(2). 265–269. 9 indexed citations
17.
Verhagen, A. M. W., Wayne G. Kimpton, & Andrew D. Nash. (1994). Development of a sandwich immunoassay for the detection of soluble ovine IL-2Rα chain. Veterinary Immunology and Immunopathology. 42(3-4). 287–300. 3 indexed citations
18.
Bowles, Vernon M, et al.. (1994). The immune response of sheep infected with larvae of the sheep blowfly Lucilia cuprina monitored via efferent lymph. Veterinary Immunology and Immunopathology. 40(4). 341–352. 15 indexed citations
19.
Egan, Paul J., J.S. Rothel, Arna E. Andrews, et al.. (1994). Characterization of monoclonal antibodies to ovine tumor necrosis factor-α and development of a sensitive immunoassay. Veterinary Immunology and Immunopathology. 41(3-4). 259–274. 31 indexed citations
20.
Nash, Andrew D., Garry Barcham, Arna E. Andrews, & Malcolm R. Brandon. (1992). Characterisation of ovine alveolar macrophages: regulation of surface antigen expression and cytokine production. Veterinary Immunology and Immunopathology. 31(1-2). 77–94. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasushi Hanakawa Breakdown of academic impact, for papers by Rami Hershkoviz Breakdown of academic impact, for papers by Gerald Grütz Breakdown of academic impact, for papers by Dagmar Scheel‐Toellner Breakdown of academic impact, for papers by Javier Mestas Breakdown of academic impact, for papers by Takao Hirano Breakdown of academic impact, for papers by Giorgio Senaldi Breakdown of academic impact, for papers by Brent Johnston Breakdown of academic impact, for papers by Marko Pesu Breakdown of academic impact, for papers by Yasuhiko Masuho
Rankless by CCL
2026